Tenaya Therapeutics, Inc.
TNYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $264,620 | $99,498 | $62,636 | $123,561 |
| - Cash | $56,312 | $62,671 | $53,772 | $4,323 |
| + Debt | $11,527 | $12,210 | $12,911 | $13,608 |
| Enterprise Value | $219,835 | $49,037 | $21,775 | $132,846 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,864 | -$2,084 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$18,411 | -$21,199 | -$24,877 | -$22,563 |
| % Margin | – | – | – | – |
| Net Income | -$20,275 | -$23,283 | -$26,864 | -$23,836 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.14 | -0.24 | -0.28 |
| % Growth | 14.3% | 41.7% | 14.3% | – |
| Operating Cash Flow | -$15,599 | -$15,613 | -$23,112 | -$18,388 |
| Capital Expenditures | -$26 | -$142 | -$383 | -$204 |
| Free Cash Flow | -$15,625 | -$15,755 | -$23,495 | -$18,592 |